Accretion Nutraveda Ltd. (ANL)
BSE
290.00
-13.00 (-4.29%)
Closed
Oct 9, 2026
Day's Range
290.00290.00
52 wk Range
150.10313.00
Financial Statements - ANL - Accretion Nutraveda Ltd.
Revenue
336.03M▲ 110.0%
Net Income
50.68M▲ 102.7%Net Margin 15.1%
EBITDA
69.32M▲ 89.8%
Free Cash Flow
-154.59M▼ 400.6%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Sales | 336.03M | 160.01M | 50.05M | 29.03M |
| Cost of Goods | 250.10M | 112.95M | 32.53M | 19.02M |
| Gross Profit | 85.92M | 47.06M | 17.51M | 10M |
 Operating Expense | - | - | - | - |
| Operating Income | 66.57M | 35.06M | 11.52M | 4.76M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 62.11M | 31.53M | 9.14M | 2.87M |
| Income Tax | 11.43M | 6.52M | 928K | 68K |
| Net Income | 50.68M | 25M | 8.21M | 2.80M |
| EPS Basic | - | 3.454282 | 1.135221 | 0.387569 |
| EPS Diluted | - | 3.454282 | 1.135221 | 0.387569 |
| Basic Shares Outstanding | - | 7.24M | 7.24M | 7.24M |
| Diluted Shares Outstanding | - | 7.24M | 7.24M | 7.24M |
| Ebit | 66.64M | 34.31M | 11.36M | 4.48M |
| Ebitda | 69.32M | 36.53M | 13.97M | 7.59M |
| Net Income Continuous Operations | 62.11M | 31.53M | 9.14M | 2.87M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
